Literature DB >> 29448005

Ratio of muscle mass to fat mass assessed by bioelectrical impedance analysis is significantly correlated with liver fat accumulation in patients with type 2 diabetes mellitus.

Noboru Kurinami1, Seigo Sugiyama2, Ayami Morita1, Akira Yoshida1, Kunio Hieshima1, Fumio Miyamoto1, Keizo Kajiwara1, Katsunori Jinnouch1, Tomio Jinnouchi1, Hideaki Jinnouchi3.   

Abstract

AIMS: Obesity and ectopic fat accumulation are important conditions of type 2 diabetes mellitus (T2DM). Our aim was to determine whether bioelectrical impedance body composition analysis combined with blood test results could estimate liver ectopic fat accumulation in patients with treatment-naïve T2DM.
METHODS: Subjects were 119 untreated T2DM patients. Computed tomography scans were performed to calculate the liver to spleen attenuation ratio (L/S ratio) as a measure of liver fat accumulation, with excess liver fat accumulation defined as an L/S ratio <1.0. Elementary body composition was measured by bioelectrical impedance analysis using InBody770.
RESULTS: The Nagelkerke R2 test showed that the muscle mass/fat mass ratio (muscle/fat ratio) was the most suitable variable among anthropometric factors and body component indexes for estimating liver fat accumulation. The muscle/fat ratio was significantly correlated with the L/S ratio (ρ = 0.4386, P < 0.0001). Multivariable logistic regression analysis showed that the muscle/fat ratio (odds ratio 0.40, 95% confidence interval 0.22-0.73, P < 0.01) and alanine aminotransferase (odds ratio 1.06, 95% confidence interval 1.02-1.10, P < 0.01) were independently and significantly associated with liver fat accumulation. In receiver operating characteristic curve analysis, the cutoff value of the muscle/fat ratio for excess liver fat accumulation was 2.34.
CONCLUSION: In patients with treatment-naïve T2DM, the muscle/fat ratio and ALT are useful for estimating the presence of excess liver fat accumulation in daily clinical practice.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Body fat; Body muscle; Diabetes mellitus; Ectopic fat accumulation; Fat; Insulin resistance; Obesity

Mesh:

Year:  2018        PMID: 29448005     DOI: 10.1016/j.diabres.2018.02.009

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  5 in total

1.  A novel probe for measuring tissue bioelectrical impedance to enhance pedicle screw placement in spinal surgery.

Authors:  Zheng Li; Chong Chen; Youxi Lin; Xingye Li; Haining Tan; Matthew Tv Chan; William Kk Wu; Songtao Zhan; Qun Cao; Jianxiong Shen
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 3.940

2.  Fat-to-muscle ratio as a predictor of insulin resistance and metabolic syndrome in Korean adults.

Authors:  Young-Gyun Seo; Hong Ji Song; Young Rim Song
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-02-07       Impact factor: 12.910

3.  Fat mass to fat-free mass ratio and the risk of non-alcoholic fatty liver disease and fibrosis in non-obese and obese individuals.

Authors:  Huajie Dai; Jiali Xiang; Yanan Hou; Liping Xuan; Tiange Wang; Mian Li; Zhiyun Zhao; Yu Xu; Jieli Lu; Yuhong Chen; Weiqing Wang; Guang Ning; Yufang Bi; Min Xu
Journal:  Nutr Metab (Lond)       Date:  2021-02-19       Impact factor: 4.169

4.  Body Muscle-to-Fat Ratio, Rather Than Fat-to-Muscle Ratio, Significantly Correlates With Measured Insulin Resistance in Patients With Type 2 Diabetes Mellitus.

Authors:  Noboru Kurinami; Seigo Sugiyama; Akira Yoshida; Kunio Hieshima; Fumio Miyamoto; Keizo Kajiwara; Katsunori Jinnouch; Tomio Jinnouchi; Masatoshi Nomura; Hideaki Jinnouchi
Journal:  J Clin Med Res       Date:  2021-07-28

5.  Association of Body Fat Percentage with Time in Range Generated by Continuous Glucose Monitoring during Continuous Subcutaneous Insulin Infusion Therapy in Type 2 Diabetes.

Authors:  Yuting Ruan; Jiana Zhong; Rongping Chen; Zhen Zhang; Dixing Liu; Jia Sun; Hong Chen
Journal:  J Diabetes Res       Date:  2021-05-28       Impact factor: 4.011

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.